← FDA DRUG APPROVALS

FDA ANDA · ANDA078147

ZALEPLON

Sponsor: HIKMA PHARMS

APPLICATION
ANDA078147
TYPE
ANDA
ORIGINAL APPROVAL
2008-11-25
LATEST ACTION
2019-12-06
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

ZALEPLONDiscontinued
ZALEPLON 10MG · CAPSULE · ORAL
ZALEPLONDiscontinued
ZALEPLON 5MG · CAPSULE · ORAL

Approval history

2019-12-06Labeling · Supplement 2 · standardAP
2008-11-25OriginalOther Important Information from FDAAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →